PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.080
+0.150 (16.13%)
At close: Apr 28, 2026, 4:00 PM EDT
1.060
-0.020 (-1.85%)
Pre-market: Apr 29, 2026, 4:54 AM EDT
PDS Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 60 | 42 | 61 | 155 | 376 | 230 | |
| Market Cap Growth | 28.92% | -30.92% | -60.56% | -58.92% | 63.37% | 383.52% | |
| Enterprise Value | 50 | 34 | 36 | 124 | 328 | 161 | |
| Last Close Price | 1.08 | 0.77 | 1.63 | 4.97 | 13.20 | 8.10 | |
| PB Ratio | 6.41 | 4.55 | 3.21 | 5.92 | 8.55 | 3.64 | |
| P/TBV Ratio | 6.52 | 4.55 | 3.21 | 5.92 | 8.55 | 3.64 | |
| Debt / Equity Ratio | 1.83 | 1.83 | 1.15 | 0.91 | 0.53 | 0.01 | |
| Net Debt / Equity Ratio | -1.06 | -1.06 | -1.04 | -1.25 | -1.14 | -1.02 | |
| Net Debt / EBITDA Ratio | 0.31 | 0.31 | 0.55 | 0.76 | 1.21 | 3.02 | |
| Net Debt / FCF Ratio | 0.35 | 0.35 | 0.57 | 0.97 | 1.96 | 5.19 | |
| Quick Ratio | 2.82 | 2.82 | 2.44 | 4.15 | 7.52 | 17.37 | |
| Current Ratio | 2.98 | 2.98 | 2.64 | 4.33 | 7.79 | 17.80 | |
| Return on Equity (ROE) | -244.16% | -244.16% | -166.65% | -122.46% | -76.21% | -37.45% | |
| Return on Assets (ROA) | -51.98% | -51.98% | -43.34% | -39.45% | -36.12% | -27.32% | |
| Return on Capital Employed (ROCE) | -150.10% | -150.10% | -128.50% | -94.10% | -62.00% | -33.80% | |
| Earnings Yield | -57.22% | -81.89% | -61.68% | -27.77% | -10.86% | -7.34% | |
| FCF Yield | -46.04% | -65.88% | -57.50% | -21.76% | -6.83% | -5.42% | |
| Buyback Yield / Dilution | -27.25% | -27.25% | -17.77% | -8.23% | -11.73% | -52.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.